Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $11.04 in the prior trading day, Anavex Life Sciences Corporation (NASDAQ: AVXL) closed at $10.74, down -2.72%. In other words, the price has decreased by -$2.72 from its previous closing price. On the day, 2.7 million shares were traded. AVXL stock price reached its highest trading level at $11.42 during the session, while it also had its lowest trading level at $10.4.
Ratios:
Our goal is to gain a better understanding of AVXL by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 8.86 and its Current Ratio is at 8.86. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Cantor Fitzgerald on December 06, 2022, Downgraded its rating to Neutral and sets its target price to $11 from $16 previously.
On June 23, 2022, Berenberg started tracking the stock assigning a Buy rating and target price of $40.
On September 23, 2021, BTIG Research started tracking the stock assigning a Buy rating and target price of $35.BTIG Research initiated its Buy rating on September 23, 2021, with a $35 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 14 ’24 when Donhauser Peter D.O. bought 2,835 shares for $3.64 per share. The transaction valued at 10,319 led to the insider holds 5,000 shares of the business.
Thomas Steffen bought 5,000 shares of AVXL for $22,600 on May 15 ’24. The Director now owns 5,000 shares after completing the transaction at $4.52 per share. On Mar 28 ’24, another insider, MISSLING CHRISTOPHER U, who serves as the President and CEO of the company, sold 73,380 shares for $5.11 each. As a result, the insider received 374,972 and left with 1,250,210 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AVXL now has a Market Capitalization of 910918464 and an Enterprise Value of 593029312.
Stock Price History:
Over the past 52 weeks, AVXL has reached a high of $14.44, while it has fallen to a 52-week low of $3.25. The 50-Day Moving Average of the stock is 29.01%, while the 200-Day Moving Average is calculated to be 85.11%.
Shares Statistics:
The stock has traded on average 1.52M shares per day over the past 3-months and 3147950 shares per day over the last 10 days, according to various share statistics. A total of 84.80M shares are outstanding, with a floating share count of 82.12M. Insiders hold about 3.18% of the company’s shares, while institutions hold 31.86% stake in the company. Shares short for AVXL as of 1732838400 were 19693094 with a Short Ratio of 13.70, compared to 1730332800 on 18308959. Therefore, it implies a Short% of Shares Outstanding of 19693094 and a Short% of Float of 23.959999.
